Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Zaleplon is a chemically novel hypnotic that preferentially binds alpha(1)-subunit containing subtypes of the alphabetagamma configuration of the gamma-aminobutyric acid (GABA)(A) receptor. Zaleplon and the non-subtype-selective hypnotic triazolam occasioned 100% drug-appropriate responding in baboons trained to discriminate lorazepam or pentobarbital from vehicle. Flumazenil shifted the zaleplon generalization gradient at least five-fold to the right. A plasma elimination half-life of 6-8 h for oral 10 mg/kg zaleplon and 0.32 mg/kg triazolam was paralleled by discriminative control for 7 h. Zaleplon maintained self-injection greater than vehicle, as did comparison doses of the similarly selective hypnotic zolpidem and triazolam. Concurrent food-maintained responding increased during self-injection of all three drugs. Preferential binding at this alpha(1)-containing GABA(A) subtype did not diminish the benzodiazepine (Bzs)-like behavioral effects of zaleplon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Circumstantial evidence stems from the fact that α 1-preferential affinity-selective compounds such as zolpidem produce physical dependence [165]”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [165]
Citations
Cites
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C., & Beer, B. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90125-4 · Cited by 407
Zolpidem: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential
Langtry, H. D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199040020-00008 · Cited by 297
Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
Evans, S. M., Funderburk, F. R., & Griffiths, R. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23193-7 · Cited by 165
Pharmacokinetics of the Newer Benzodiazepines
Garzone, P. D., & Kroboth, P. D. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916060-00002 · Cited by 164
Beyond Benzodiazepines: Alternative Pharmacologic Agents for the Treatment of Insomnia
Wagner, J., Wagner, M. L., & Hening, W. A. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17111 · Cited by 161
Cooper, S. J., & Estall, L. B. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90028-4 · Cited by 129
Drug discrimination analysis of endogenous neuroactive steroids in rats
Ator, N. A., Grant, K. A., Purdy, R. H., Paul, S. M., & Griffiths, R. R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90208-y · Cited by 116
Self-citationGriffiths, R. R., Sannerud, C. A., Ator, N. A., & Brady, J. V. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11429-8 · Cited by 112 · cited 7×
“The Bz1/v1-selective compound zolpidem also shared discriminative effects with pentobarbital when it was tested in these same baboons (Griffiths et al., 1992).”
BackgroundResultInfluentialSelf-citationLack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
Perrault, G., Morel, E., Sanger, D. J., & Zivkovic, B. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10339-x · Cited by 110
Research works printed but not linked: 1
- Sieghart, 1995, Structure and pharmacology of γ-aminobutyric acid(A) receptor subtypes, Pharmacol. Rev., 47, 181
Cited by
Griffiths, R. R., & Johnson, M. W. (2005) · PubMed · Cited by 260
Principles of drug abuse liability assessment in laboratory animals
Ator, N. A., & Griffiths, R. R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00099-1 · Cited by 249
Self-citationAbuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Circumstantial evidence stems from the fact that α1-preferential affinity-selective compounds such as zolpidem produce physical dependence [165], even though the compound TPA123 that possesses 23% efficacy at the α1 subunit (but is not affinity selective) did also result in physical dependence [8].”
BackgroundTreating insomnia: Current and investigational pharmacological approaches
Ebert, B., Wafford, K. A., & Deacon, S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.014 · Cited by 166
Metadata
- Authors
- Ator, N. A.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Ator, N.A
- ORCID
- Ator, N.A
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 61
- Issue
- 1
- Pages
- 55-68
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2063548396
- Cited by
- 35
- References
- 43
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 2 · 2016: 2 · 2015: 1 · 2014: 1 · 2012: 3
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01-DA-04133, R01DA004133)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- zaleplon, triazolam, zolpidem, hypnotics, GABA-A receptor alpha1 subunit, drug discrimination, plasma half-life, self-administration, flumazenil, lorazepam, pentobarbital, food-maintained responding, benzodiazepine-like effects, baboons
- MeSH terms
- Acetamides, Animals, Behavior, Animal, Discrimination Learning, Dose-Response Relationship, Drug, Hypnotics and Sedatives, Male, Papio, Pyrimidines, Self Administration, Triazolam, GABA Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons. https://app.cochat.ai/papers/10.1016/s0376-8716(00)00123-x
- The paper
- Ator, N. A. (2000). Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons. Drug and Alcohol Dependence. https://doi.org/10.1016/s0376-8716(00)00123-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.